| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC3511 |
| Trial ID | NCT05946226 |
| Disease | Digestive System Tumor |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | IMC002 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I, Open-label, Multi-center, Dose-escalation Study to Evaluate the Safety, Feasibility, and Preliminary Efficacy of IMC002 in Patients With Claudin18.2-positive Advanced Digestive System Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Suzhou Immunofoco Biotechnology Co., Ltd |
| Other ID(s) | IMC002-RT01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||